VITUP International Hospital provides advanced ultrasound, digital X-ray examination, four-dimensional abdominal screening, pelvic ultrasonography, ABVS (Automated Breast Volume Scanner) full volume ultrasonography, dual energy X-ray density analysis and body composition analysis. By using such advanced methods, VITUP physicians can provide an accurate diagnosis and treatment recommendation.
X-Ray, Mammography and Ultrasound
Breast ultrasound examination and X-ray examination complement each other. Ultrasound can determine whether breast tumors are solid or cystic. Ultrasound can also recognize increased blood flow, which is an indicator of possible tumor growth. If a mass is found in a breast x-ray, further examination to determine its nature and to distinguish whether the mass is benign or malignant is critical.
We recommend that women above the age of 30 receive a mammogram every year. More frequent checks are recommended if there are high risk factors.
Breast ABVS Full Volume Ultrasound
Breast ultrasound is non-invasive and often used as a follow-up test after an abnormal finding on a mammogram, breast MRI or clinical breast exam. VITUP uses a Siemens ACUSON S2000 ABVS, a highly advanced ultrasound system that plays a key role in breast cancer detection, particularly among high-risk patients. It provides comfortable imaging for women regardless of whether they’re asymptomatic or have a known history of breast disease or dense breast tissue.
The ABVS is especially suited for diagnoses of exceptionally dense breast tissue thanks to its 3D image acquisition technology.
Peritoneal and Pelvic Ultrasound
Ovarian cancer is frequently detected late, so patient survival rates are lower. If detected early, the course of treatment can be more accurately predicted and better results can be achieved. It is recommended that women undergo an endometrial and ovarian ultrasonography every year after menopause or undergo biochemical tumor testing to enable early detection of lesions.
With a family history of ovarian cancer, examinations should be conducted five years prior to the cancer onset of their immediate family members. Women who have been treated with estrogen for infertility have a higher chance of suffering from ovarian cancer and should be routinely checked every year.
Ultrasound is an important tool in the diagnosis of gynecological cancers, the assessment of tumor extent in the pelvic and abdominal cavity, and the evaluation of treatment effects as well as follow-up after treatment. Ultrasound is the method of choice for evaluating local extent of endometrial cancer and is the most important imaging method for the differential diagnosis of benign and malignant ovarian tumors.
Primary peritoneal cancer is a very rare form of cancer and is more common in women than in men. Women at risk of ovarian cancer are also at increased risk for peritoneal cancer. This is even more likely if you have the BRCA1 and BRCA2 genetic mutations. Older age is another risk factor for peritoneal cancer.